224 related articles for article (PubMed ID: 32191918)
1. Time-dependent interactions of blood platelets and cancer cells, accompanied by extramedullary hematopoiesis, lead to increased platelet activation and reactivity in a mouse orthotopic model of breast cancer - implications for pulmonary and liver metastasis.
Kassassir H; Karolczak K; Siewiera KM; Wojkowska DW; Braun M; Watala CW
Aging (Albany NY); 2020 Mar; 12(6):5091-5120. PubMed ID: 32191918
[TBL] [Abstract][Full Text] [Related]
2. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.
Gareau AJ; Brien C; Gebremeskel S; Liwski RS; Johnston B; Bezuhly M
Clin Exp Metastasis; 2018 Feb; 35(1-2):25-35. PubMed ID: 29322294
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions.
Wenzel J; Zeisig R; Fichtner I
Clin Exp Metastasis; 2010; 27(1):25-34. PubMed ID: 19916050
[TBL] [Abstract][Full Text] [Related]
4. Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process.
Pang JH; Coupland LA; Freeman C; Chong BH; Parish CR
Clin Exp Metastasis; 2015 Jun; 32(5):495-505. PubMed ID: 25982688
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide deficiency and endothelial-mesenchymal transition of pulmonary endothelium in the progression of 4T1 metastatic breast cancer in mice.
Smeda M; Kieronska A; Adamski MG; Proniewski B; Sternak M; Mohaissen T; Przyborowski K; Derszniak K; Kaczor D; Stojak M; Buczek E; Jasztal A; Wietrzyk J; Chlopicki S
Breast Cancer Res; 2018 Aug; 20(1):86. PubMed ID: 30075800
[TBL] [Abstract][Full Text] [Related]
6. Platelet deficiency in Tpo
Thiele W; Rothley M; Dimmler A; Bugert P; Salomó Coll C; Sleeman JP
Clin Exp Metastasis; 2018 Oct; 35(7):679-689. PubMed ID: 30043083
[TBL] [Abstract][Full Text] [Related]
7. Unexpected effects of long-term treatment with acetylsalicylic acid on late phase of pulmonary metastasis in murine model of orthotopic breast cancer.
Smeda M; Kij A; Proniewski B; Matyjaszczyk-Gwarda K; Przyborowski K; Jasztal A; Derszniak K; Berkowicz P; Kieronska-Rudek A; Stojak M; Sternak M; Chlopicki S
PLoS One; 2020; 15(4):e0230520. PubMed ID: 32251451
[TBL] [Abstract][Full Text] [Related]
8. Temporal inhibition of mouse mammary gland cancer metastasis by CORM-A1 and DETA/NO combination therapy.
Porshneva K; Papiernik D; Psurski M; Łupicka-Słowik A; Matkowski R; Ekiert M; Nowak M; Jarosz J; Banach J; Milczarek M; Goszczyński TM; Sieńczyk M; Wietrzyk J
Theranostics; 2019; 9(13):3918-3939. PubMed ID: 31281522
[TBL] [Abstract][Full Text] [Related]
9. Platelet TLR4-ERK5 Axis Facilitates NET-Mediated Capturing of Circulating Tumor Cells and Distant Metastasis after Surgical Stress.
Ren J; He J; Zhang H; Xia Y; Hu Z; Loughran P; Billiar T; Huang H; Tsung A
Cancer Res; 2021 May; 81(9):2373-2385. PubMed ID: 33687949
[TBL] [Abstract][Full Text] [Related]
10. Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived galectin-3.
Mammadova-Bach E; Gil-Pulido J; Sarukhanyan E; Burkard P; Shityakov S; Schonhart C; Stegner D; Remer K; Nurden P; Nurden AT; Dandekar T; Nehez L; Dank M; Braun A; Mezzano D; Abrams SI; Nieswandt B
Blood; 2020 Apr; 135(14):1146-1160. PubMed ID: 32040544
[TBL] [Abstract][Full Text] [Related]
11. Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis.
Echtler K; Konrad I; Lorenz M; Schneider S; Hofmaier S; Plenagl F; Stark K; Czermak T; Tirniceriu A; Eichhorn M; Walch A; Enders G; Massberg S; Schulz C
PLoS One; 2017; 12(3):e0172788. PubMed ID: 28253287
[TBL] [Abstract][Full Text] [Related]
12. Combination Therapy with DETA/NO and Clopidogrel Inhibits Metastasis in Murine Mammary Gland Cancer Models via Improved Vasoprotection.
Porshneva K; Papiernik D; Psurski M; Nowak M; Matkowski R; Ekiert M; Milczarek M; Banach J; Jarosz J; Wietrzyk J
Mol Pharm; 2018 Nov; 15(11):5277-5290. PubMed ID: 30234992
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis.
Qian W; Tao L; Wang Y; Zhang F; Li M; Huang S; Wang A; Chen W; Yue Z; Chen L; Liu Y; Huang C; Zhang L; Li Y; Lu Y
J Vasc Res; 2015; 52(3):197-209. PubMed ID: 26488158
[TBL] [Abstract][Full Text] [Related]
14. Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.
Zhang F; Dong W; Zeng W; Zhang L; Zhang C; Qiu Y; Wang L; Yin X; Zhang C; Liang W
Breast Cancer Res; 2016 Apr; 18(1):38. PubMed ID: 27036297
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer stem-like cells can promote metastasis by activating platelets and down-regulating antitumor activity of natural killer cells.
Wang S; Zhang Y; Cong W; Liu J; Zhang Y; Fan H; Xu Y; Lin H
J Tradit Chin Med; 2016 Aug; 36(4):530-7. PubMed ID: 28459521
[TBL] [Abstract][Full Text] [Related]
16. TANK-binding kinase 1 is a mediator of platelet-induced EMT in mammary carcinoma cells.
Zhang Y; Unnithan RVM; Hamidi A; Caja L; Saupe F; Moustakas A; Cedervall J; Olsson AK
FASEB J; 2019 Jul; 33(7):7822-7832. PubMed ID: 30912981
[TBL] [Abstract][Full Text] [Related]
17. Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study.
Salgado R; Benoy I; Bogers J; Weytjens R; Vermeulen P; Dirix L; Van Marck E
Angiogenesis; 2001; 4(1):37-43. PubMed ID: 11824377
[TBL] [Abstract][Full Text] [Related]
18. OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung.
Tawara K; Bolin C; Koncinsky J; Kadaba S; Covert H; Sutherland C; Bond L; Kronz J; Garbow JR; Jorcyk CL
Breast Cancer Res; 2018 Jun; 20(1):53. PubMed ID: 29898744
[TBL] [Abstract][Full Text] [Related]
19. Glycosaminoglycans as Tools to Decipher the Platelet Tumor Cell Interaction: A Focus on P-Selectin.
Schwarz S; Gockel LM; Naggi A; Barash U; Gobec M; Bendas G; Schlesinger M
Molecules; 2020 Feb; 25(5):. PubMed ID: 32110917
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer.
Andrade SS; Gouvea IE; Silva MC; Castro ED; de Paula CA; Okamoto D; Oliveira L; Peres GB; Ottaiano T; Facina G; Nazário AC; Campos AH; Paredes-Gamero EJ; Juliano M; da Silva ID; Oliva ML; Girão MJ
BMC Cancer; 2016 Mar; 16():173. PubMed ID: 26931461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
